British Journal of Haematology

Aims & Scope

The mission of the British Journal of Haematology (BJHaem) is to inform and educate its readership in all aspects of the clinical and laboratory practice of haematology, extending from its scientific basis, through translational research, to clinical trials and daily practice.

The journal welcomes manuscripts in cutting edge science and new treatments including targeted therapy, molecular and gene therapy and immunotherapy.

The journal also focuses on evidence-based medicine by publishing peer-reviewed Guidelines on various basic and clinical subjects resulting from committees formed by the British Society for Haematology.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.8
2024	5.10

Journal Rank

Year	Value
2024	2042

Journal Citation Indicator

Year	Value
2024	5244

SJR (SCImago Journal Rank)

Year	Value
2024	1.647

Quartile

Year	Value
2024	Q1

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Proposals for the Classification of the Acute Leukaemias F<scp>rench</scp>‐A<scp>merican</scp>‐B<scp>ritish</scp> (FAB) C<scp>o‐operative</scp> G<scp>roup</scp>

  Citation: 4247

  Authors: J. M., D., Marie‐Theregse, G., D. A. G., H. R., C.

• Proposals for the classification of the myelodysplastic syndromes

  Citation: 2619

  Authors: J. M., D., M. T., G., D. A. G., H. R., C.

• Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

  Citation: 1847

  Authors:

• Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma

  Citation: 1421

  Authors: Charles H., Shira, Heather M., Beena, Amanda P., Karen, Alison H., Francesco, Jacqueline, James S., Christian S. R., Adrian L.

• The Nature and Significance of Platelet Products in Human Plasma

  Citation: 1365

  Authors: Peter

• Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma

  Citation: 1322

  Authors: M.

• CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION

  Citation: 1233

  Authors: Joan, Diana, Donna, Jane, Bo, GÖsta, Morie, Sergio, SUNDARr, David

• Mesenchymal progenitor cells in human umbilical cord blood

  Citation: 1211

  Authors: Alejandro, Paulette, José J.

• Guidelines for the diagnosis and management of disseminated intravascular coagulation

  Citation: 871

  Authors: M, C. H., J, H. G.

• Tumour lysis syndrome: new therapeutic strategies and classification

  Citation: 790

  Authors: Mitchell S., Michael

---